Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Dupilumab can both trigger and treat alopecia areata, often leading to hair regrowth.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

BMS-470539 reduces skin fibrosis and inflammation.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.